I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Azacitidine Venetoclax and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome
This phase II trial investigates how well azacitidine, venetoclax, and trametinib work in treating patients with acute myeloid leukemia or higher-risk myelodysplastic syndrome that has come back (relapsed) or has not responded to treatment (refractory). Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer …
refractory myelodysplastic syndrome
recurrent chronic myelomonocytic leukemia
refractory chronic myelomonocytic leukemia (cmml)
leukemia relapse
myeloid leukemia
- 0 views
- 19 Feb, 2024